miR-210 inhibits cell migration and invasion by targeting the brain-derived neurotrophic factor in glioblastoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are increasingly implicated in glioblastoma (GBM) development, diagnosis, treatment, and prognosis.
• The specific role of microRNA-210 (miR-210) in glioblastoma remains largely undefined.

Purpose of the Study:

• To investigate the biological function and molecular mechanisms of miR-210 in glioblastoma.
• To determine the relationship between miR-210 expression levels and glioblastoma patient prognosis.

Main Methods:

• Quantitative analysis of miR-210 expression in glioblastoma tissues.
• Cellular assays to assess the effects of miR-210 overexpression on glioblastoma cell migration and invasion.
• Target validation experiments to identify direct targets of miR-210, including brain-derived neurotrophic factor (BDNF).

Main Results:

• miR-210 expression was found to be decreased in glioblastoma tissues.
• Lower miR-210 levels correlated with a worse prognosis in glioblastoma patients.
• Overexpression of miR-210 significantly inhibited glioblastoma cell migration and invasion.
• miR-210 was identified as a direct targeting molecule of BDNF, leading to reduced BDNF expression.
• Silencing BDNF mimicked the inhibitory effects of miR-210 overexpression, while BDNF upregulation counteracted miR-210's inhibitory actions.

Conclusions:

• miR-210 functions as a tumor suppressor in glioblastoma.
• miR-210 suppresses glioblastoma cell migration and invasion through direct targeting of BDNF.
• These findings highlight miR-210 as a potential therapeutic target for glioblastoma.